# Microsynbiotix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/microsynbiotix

- Industry: Biotechnology
- Headquarters: Cork, Ireland
- Website: www.microsynbiotix.com
- Total disclosed funding: $1.3M
- Latest round: Seed (Sep 5, 2017)
- Investors on record: 5

## About

Microsynbiotix, Ltd. specializes in developing innovative biological solutions for the aquaculture industry, focusing on effective and environmentally safe products that address challenges related to aquatic ecosystems.Founded in 2016, Microsynbiotix, Ltd. is a subsidiary of Sundew ApS, which acquired the company in November 2021 from its previous investors, including RebelBio, SOSV, Alimentos Ventures, Enterprise Ireland, and The Yield Lab. The company is headquartered in Cork, Ireland. Simon J, the founder, has a history in the biotech industry. The latest funding round was a Seed round in which the company raised EUR 1.000 mn, bringing the total amount raised to EUR 1.000 mn, with investments from notable entities such as Alimentos Ventures and Enterprise Ireland.Microsynbiotix focuses on developing biological solutions to tackle significant aquatic ecosystem challenges. The company’s key offerings include Biokos®, a natural active ingredient derived from marine organisms that effectively combats various fish parasites, and specialized microalgal delivery systems for RNA and antigens. Their products cater to fish breeders and producers, emphasizing sustainable practices in aquaculture. Biokos® is recognized for its ease of use and rapid breakdown in water, aligning with the growing focus on environmentally friendly aquaculture solutions in Europe and North America.In 2022, Microsynbiotix reported revenue of EUR 0.00 and an EBITDA of EUR 0.00. The company’s revenue model is based on direct sales of its biological products to B2B clients, with a focus on enhancing market reach through partnerships with selected distributors.Microsynbiotix is actively working on the design and launch of new products aimed at enhancing sustainability in aquaculture. Targeted geographic expansions are planned for emerging markets in Europe and North America by 2023. The recent Seed funding of EUR 1.000 mn will be strategically utilized to support these product developments and market expansion initiatives.

## Funding rounds

- Seed, Sep 5, 2017, $1.2M — Enterprise Ireland, SOSV, The Yield Lab, RebelBio, Alimentos Ventures
- Seed, May 13, 2016, $0.1M — SOSV, RebelBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- RebelBio — Seed
- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Seed
- The Yield Lab (https://capitalatlas.ai/funds/the-yield-lab) — Seed
- Alimentos Ventures — Seed